Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease
Seminars in Cancer Biology · 2026
DOI: 10.1016/j.semcancer.2026.01.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2026. Verfasst von Maria Llena-Meler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Medicina Preventiva y Salud Pública, Universitat de València (UV), Spain. Hauptthemen laut MEDLINE: Neoplasms, Cardiovascular Diseases, Lipid Metabolism. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 354 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Generalitat de Catalunya, Spanish Association Against Cancer Scientific Foundation.
Abstract (Originalsprache)
Obesity-induced chronic inflammation and lipid metabolic imbalance form a pivotal nexus linking cardiovascular disease and cancer. Dysfunctional adipose tissue establishes a pro-inflammatory environment through hypoxia-driven macrophage polarization, oxidative stress, aberrant lipid signaling, and endocrine crosstalk, mechanisms that collectively foster atherogenesis and tumor promotion. Yet, a comprehensive integration of metabolic and immunological dynamics at the molecular level remains elusive. In this review, we synthesize emerging evidence that metabolic stressors, particularly excessive intake of oxidized and omega-6-enriched lipids, activate NF-κB and NLRP3-dependent inflammatory pathways in macrophages, thereby fostering a pro-tumorigenic and pro-atherogenic microenvironment. We underscore the emerging role of microRNAs as functional mediators connecting lipid metabolism, inflammation, and cellular plasticity across atherosclerotic and neoplastic tissues. These non-coding RNAs modulate key signaling pathways, including the critical PI3K/Akt, NFκB, and TGFβ axes, thereby promoting macrophage phenotype shifts, endothelial dysfunction, aberrant proliferation, and immune evasion. Importantly, interventions aimed at restoring lipid homeostasis, including Mediterranean-style diets, caloric restriction, and regular physical activity, act as important regulators of systemic and tissue-specific inflammation. Nutritional interventions increase monounsaturated and omega-3 fatty acid content and limit oxidized lipid exposure. We propose that combining metabolic modulation with RNA-based therapies, such as miRNA mimics or inhibitors delivered through nanoparticles or pH-responsive peptide systems, may offer synergistic avenues for controlling metabolic inflammation in both cancer and cardiovascular disease. Future research should focus on the targeted and context-dependent regulation of non-coding RNA networks within immuno-metabolic circuits, advancing precision medicine in cardio-oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Medicina Preventiva y Salud Pública, Universitat de València (UV), Spain.
- Department of Microbiology New York University Grossman School of Medicine, New York, NY 10016, USA.
- Departamento de Medicina Preventiva y Salud Pública, Universitat de València (UV), Spain; Instituto Biomédico de Nutrición y Salud (IBIONS), Spain. Electronic address: julio.madrigal@uv.es.
- Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: nrotllanv@santpau.cat.
Förderung
- Instituto de Salud Carlos III
- Generalitat de Catalunya
- Spanish Association Against Cancer Scientific Foundation
- European Commission
- American Heart Association Inc
- Espana Ministerio de Ciencia e Innovacion
- European Regional Development Fund
- Agencia Estatal de Investigación
Zitieren
APA
Llena-Meler, M., Canfran-Duque, A., Madrigal-Matute, J., & Rotllan, N. (2026). Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2026.01.003
Vancouver
Llena-Meler M, Canfran-Duque A, Madrigal-Matute J, Rotllan N. Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease. Seminars in Cancer Biology. 2026. doi:10.1016/j.semcancer.2026.01.003
BibTeX
@article{LlenaMeler2026,
author = {Llena-Meler, Maria and Canfran-Duque, Alberto and Madrigal-Matute, Julio and Rotllan, Noemi},
title = {Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease},
journal = {Seminars in Cancer Biology},
year = {2026},
doi = {10.1016/j.semcancer.2026.01.003}
}
EUVIMED